# Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia

> **NCT02931474** · PHASE2 · WITHDRAWN · sponsor: **National Institute of Nursing Research (NINR)**

## Conditions studied

- Sleep Disorder
- Traumatic Brain Injury

## Interventions

- **DRUG:** Tesamorelin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02931474
- **Lead sponsor:** National Institute of Nursing Research (NINR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-10-06
- **Primary completion:** 2017-03-08
- **Final completion:** 2017-03-08
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02931474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02931474, "Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02931474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*